Finasteride Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-09-11　·　259 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 150.0 Mn
2033 年預估規模: USD 194.5 Mn
年複合成長率 CAGR: 3.8%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

完整報告名稱與涵蓋範圍

Finasteride Market, By Product Type (1 mg, 5 mg, Topical Finasteride), By Indication (Benign Prostatic Hyperplasia (BPH), Male Pattern Baldness / Androgenetic Alopecia), By Formulation (Tablet, Topical Solution, Topical Foam), By End User (Dermatology Clinics, Urology Clinics, Hospitals, Home Care, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

報告摘要

The global finasteride market is estimated to be valued at USD 150.0 Mn in 2026 and is expected to reach USD 194.5 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 3.8% from 2026 to 2033. Finasteride is a synthetic 4-azasteroid that selectively inhibits 5α-reductase type II and decreases the conversion of testosterone to dihydrotestosterone (DHT). It was first approved for benign prostatic hyperplasia (BPH) and later for androgenetic alopecia (male pattern hair loss). Finasteride is available mainly as 1 mg and 5 mg oral preparations and is widely used in urology and dermatology. The global finasteride market is segmented into branded and generic players, distributors, and healthcare providers. The market is expected to be driven by the growth of the aging male population, the rising prevalence of BPH, the increasing awareness of hair loss treatment, the availability of generics, and the ongoing development of alternative formulations such as topical finasteride, while evolving regulatory requirements and off-label use are expected to continue shaping the market landscape. Market Dynamics The global finasteride market is driven by the increasing number of aging men and the rising incidence of BPH. This is in conjunction with the increasing awareness about androgenetic alopecia and the need for hair-loss treatments. The wider availability of generic finasteride, increasing healthcare access in emerging economies, and the growth of telehealth and digital prescribing channels are further aiding market penetration. However, a number of constraints are present in the market, such as adverse effects, patient hesitancy, long-term treatment requirements, and competition from alternatives such as dutasteride and minoxidil. Nevertheless, significant opportunities exist in topical finasteride formulations, combination therapies, digital healthcare platforms and emerging markets. Key Features of the Study • This report provides in-depth analysis of the global finasteride market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global finasteride market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Viatris Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Aurobindo Pharma Ltd., Lupin Ltd., and Torrent Pharmaceuticals Ltd. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global finasteride market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global finasteride market Market Segmentation • Product Type Insights (Revenue, USD Mn, 2021 - 2033) o 1 mg o 5 mg o Topical Finasteride • Indication Insights (Revenue, USD Mn, 2021 - 2033) o Benign Prostatic Hyperplasia (BPH) o Male Pattern Baldness / Androgenetic Alopecia • Formulation Insights (Revenue, USD Mn, 2021 - 2033) o Tablet o Topical Solution o Topical Foam • End User Insights (Revenue, USD Mn, 2021 - 2033) o Dermatology Clinics o Urology Clinics o Hospitals o Home Care o Others • Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033) o Retail Pharmacies o Hospital Pharmacies o Online Pharmacies • Regional Insights (Revenue, USD Mn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Merck & Co., Inc. o Teva Pharmaceutical Industries Ltd. o Sandoz Group AG o Viatris Inc. o Sun Pharmaceutical Industries Ltd. o Reddy's Laboratories Ltd. o Cipla Ltd. o Aurobindo Pharma Ltd. o Lupin Ltd. o Torrent Pharmaceuticals Ltd.

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global Finasteride Market, By Product Type  Global Finasteride Market, By Indication  Global Finasteride Market, By Formulation  Global Finasteride Market, By End User  Global Finasteride Market, By Distribution Channel  Global Finasteride Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Type Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Industry Trends 4. Global Finasteride Market, By Product Type, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o 1 mg  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o 5 mg  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Topical Finasteride  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 5. Global Finasteride Market, By Indication, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Benign Prostatic Hyperplasia (BPH)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Male Pattern Baldness / Androgenetic Alopecia  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 6. Global Finasteride Market, By Formulation, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Tablet  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Topical Solution  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Topical Foam  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 7. Global Finasteride Market, By End User, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Dermatology Clinics  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Urology Clinics  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Hospitals  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Home Care  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 8. Global Finasteride Market, By Distribution Channel, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Retail Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Hospital Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Online Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 9. Global Finasteride Market, By Region, 2021 - 2033, Value (USD Mn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn) o South Africa o North Africa o Central Africa 10. Competitive Landscape o Merck & Co., Inc.  Company Highlights  Product Type Portfolio  Key Developments  Financial Performance  Strategies o Teva Pharmaceutical Industries Ltd.  Company Highlights  Product Type Portfolio  Key Developments  Financial Performance  Strategies o Sandoz Group AG  Company Highlights  Product Type Portfolio  Key Developments  Financial Performance  Strategies o Viatris Inc.  Company Highlights  Product Type Portfolio  Key Developments  Financial Performance  Strategies o Sun Pharmaceutical Industries Ltd.  Company Highlights  Product Type Portfolio  Key Developments  Financial Performance  Strategies o Reddy's Laboratories Ltd.  Company Highlights  Product Type Portfolio  Key Developments  Financial Performance  Strategies o Cipla Ltd.  Company Highlights  Product Type Portfolio  Key Developments  Financial Performance  Strategies o Aurobindo Pharma Ltd.  Company Highlights  Product Type Portfolio  Key Developments  Financial Performance  Strategies o Lupin Ltd.  Company Highlights  Product Type Portfolio  Key Developments  Financial Performance  Strategies o Torrent Pharmaceuticals Ltd.  Company Highlights  Product Type Portfolio  Key Developments  Financial Performance  Strategies 11. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 12. References and Research Methodology o References o Research Methodology o About us Browse 32 market data tables and 28 figures on ‘Finasteride Market' - Global forecast to 2033

提及公司

Merck & Co., Inc.Teva Pharmaceutical Industries Ltd.Sandoz Group AGViatris Inc.Sun Pharmaceutical Industries Ltd.Reddy's Laboratories Ltd.Cipla Ltd.Aurobindo Pharma Ltd.Lupin Ltd.Torrent Pharmaceuticals Ltd.

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們